Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Shares Issued (2022 - 2025)

Historic Shares Issued for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to $3.6 million.

  • Centessa Pharmaceuticals' Shares Issued fell 1608.95% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.4 million, marking a year-over-year increase of 10609.7%. This contributed to the annual value of $11.2 million for FY2024, which is 352161.29% up from last year.
  • As of Q3 2025, Centessa Pharmaceuticals' Shares Issued stood at $3.6 million, which was down 1608.95% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Centessa Pharmaceuticals' Shares Issued ranged from a high of $5.3 million in Q4 2024 and a low of $12000.0 during Q2 2023
  • In the last 4 years, Centessa Pharmaceuticals' Shares Issued had a median value of $568500.0 in 2022 and averaged $1.4 million.
  • Per our database at Business Quant, Centessa Pharmaceuticals' Shares Issued plummeted by 8285.71% in 2023 and then surged by 658333.33% in 2024.
  • Over the past 4 years, Centessa Pharmaceuticals' Shares Issued (Quarter) stood at $89000.0 in 2022, then soared by 32.58% to $118000.0 in 2023, then skyrocketed by 4427.12% to $5.3 million in 2024, then crashed by 33.32% to $3.6 million in 2025.
  • Its last three reported values are $3.6 million in Q3 2025, $1.7 million for Q2 2025, and $1.8 million during Q1 2025.